Skip to main content
. 2021 Aug 5;35(9):e23946. doi: 10.1002/jcla.23946

TABLE 3.

GC genotype and allele frequencies

All patients

(n = 83)

Sarcopenia

(n = 35)

Non‐sarcopenia

(n = 48)

p Value
GC genotype
Gc1f‐1f 25 (30.1%) 11 (31.4%) 14 (29.2%) 0.532
Gc1s‐1f 22 (26.5%) 12 (34.3%) 10 (20.8%)
Gc1s‐1s 4 (4.8%) 1 (2.9%) 3 (6.3%)
Gc2‐1f 19 (22.9%) 6 (17.1%) 13 (27.1%)
Gc2‐1s 10 (12.1%) 3 (8.6%) 7 (14.6%)
Gc2‐2 3 (3.6%) 2 (5.7%) 1 (2.1%)
GC allele
Gc1f 91 (54.8%) 40 (57.1%) 51 (53.1%) 0.785
Gc1s 40 (24.1%) 17 (24.3%) 23 (24.0%)
Gc2 35 (21.1%) 13 (18.6%) 22 (22.9%)

Data were presented as number (percentage).